About this trial
The PERFORM registry is a structured, real-world data platform designed to systematically capture patient characteristics, disease severity and treatment patterns of Erectile Dysfunction (ED) across Pakistan. By reflecting routine clinical practice, an ED registry provides valuable insights into the disease epidemiology, unmet needs, and variations in care across populations. It supports evidence-based decision-making, helps identifying early predictors, and inform guideline development, health policy, and personalized management strategies in male sexual health.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult male above 18 years of age
Married
Diabetic
Patient reports erectile dysfunction (symptomatic).
Disqualifiers
If at any other PDE-5 inhibitor (sildenafil, tadalafil, vardenafil, avanafil)
Concurrent use of organic nitrates (any form: glyceryl trinitrate, isosorbide mononitrate/dinitrate) - absolute contraindication
Recent or unstable cardiovascular disease
Myocardial infarction or stroke in last 3 months
Trial population
Adult Male ED patients
Trial design
Case-only
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Descriptive data of frequency, severity of ED in Pakistan
Prevalence
Descriptive data [age, income (derivative of socio-economic class), rural/urban population and occupation]
Demographics
Secondary outcomes
Age of diabetes in ED patients
Duration of diabetes in ED patients
Duration of ED
Disease duration
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Nabiqasim Industries (Pvt) Ltd
Lead sponsor
Pakistan Society of Internal Medicine
Collaborator
This trial is not recruiting at the moment. You can still explore other options: